The clinical utility of L-type Wako <I>H. pylori</I> antibody J test and SphereLight <I>H. pylori</I> antibody J test for assessing the risk of gastric cancer

DOI Web Site

Bibliographic Information

Other Title
  • 胃がんリスク診断におけるLタイプワコーH.ピロリ抗体・J及びスフィアライトH.ピロリ抗体・Jの有用性
  • イガン リスク シンダン ニ オケル Lタイプワコー H.ピロリ コウタイ ・ J オヨビ スフィアライト H.ピロリ コウタイ ・ J ノ ユウヨウセイ

Search this article

Description

Serum ABC classification has been attracting research attention for predicting the risk of gastric cancer. In this study, we evaluated the clinical utility of L-type Wako H. pylori antibody J test (Wako Ltx method) and SphereLight H. pylori antibody J test (Wako CLEIA method) for assessing the risk of gastric cancer. A total of 833 healthy adults without a history of Helicobacter pylori (Hp) eradication and gastrectomy were enrolled in this study. These subjects underwent upper gastrointestinal barium X-ray radiography (MDL) in January 2010 and upper gastrointestinal endoscopy (EGD) within 1 year thereafter. Anti-Hp antibody levels were measured using E-plate Eiken H. pylori antibody II kit (E-plate method) in 2010 and remeasured in 2015 by the Wako Ltx method and the Wako CLEIA method using preserved serum samples of the same specimens. Both Hp-positive agreement rate and Hp-negative agreement rate between the methods exceeded 90% (κ > 0.85). In the group of subjects with atrophic gastritis confirmed by MDL and EGD, the sensitivity and the specificity were 96.4% and 97.0% as measured by the Wako Ltx method and 95.5% and 97.2% as measured by the Wako CLEIA method, respectively. The false-negative rate of detecting anti-Hp antibody was 10.9% with the E-plate method, whereas the Wako Ltx method and the Wako CLEIA method produced false-negative rates of 3.6% and 4.5%, respectively (p < 0.001). Moreover, in the group of subjects with atrophic gastritis, the rates of group A according to the ABC classification (group pseudo-A) were 3.2% and 2.7% as measured by the Wako Ltx method and the Wako CLEIA method, respectively, which were significantly lower than 7.2% obtained with the E-plate method (p < 0.01). Both Wako Ltx and Wako CLEIA methods showed high positive and negative agreement rates with the conventional E-plate method, whereas in comparison with the E-plate method, both methods showed significantly lower false-negative rates of detecting anti-Hp antibody and significantly lower rates of group pseudo-A in the group of subjects with atrophic gastritis. Therefore, both Wako Ltx and Wako CLEIA methods are useful in daily practice, particularly in the case of ABC screening.

Journal

Keywords

Details 詳細情報について

Report a problem

Back to top